New frontiers in nonhormonal male contraception
Contraception, ISSN: 0010-7824, Vol: 82, Issue: 5, Page: 476-482
2010
- 31Citations
- 8Usage
- 54Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations31
- Citation Indexes31
- CrossRef31
- 31
- Usage8
- Abstract Views8
- Captures54
- Readers54
- 54
Review Description
The world's population is nearing 6.8 billion, and we are in need of a male contraceptive that is safe, effective, reversible and affordable. Hormonal approaches, which employ different formulations of testosterone administered in combination with other hormones, have shown considerable promise in clinical trials, and they are currently at the forefront of research and development. However, the long-term effects of using hormones throughout a male's reproductive life for contraception are unknown, and it may take decades before this information becomes available. Because of this, many investigators are aiming to bring a nonhormonal male contraceptive to the consumer market. Indeed, there are several distinct but feasible avenues in which fertility can be regulated without affecting the hypothalamus-pituitary-testis axis. In this review, we discuss several approaches for fertility control involving the testis that one day may lead to the development of a nonhormonal male contraceptive.
Bibliographic Details
https://knowledgecommons.popcouncil.org/departments_cbr_product-development/70; https://knowledgecommons.popcouncil.org/departments_cbr_product-development/64
http://www.sciencedirect.com/science/article/pii/S0010782410001344; http://dx.doi.org/10.1016/j.contraception.2010.03.017; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=77957752496&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/20933122; https://linkinghub.elsevier.com/retrieve/pii/S0010782410001344; https://knowledgecommons.popcouncil.org/departments_cbr_product-development/70; https://knowledgecommons.popcouncil.org/cgi/viewcontent.cgi?article=1069&context=departments_cbr_product-development; https://knowledgecommons.popcouncil.org/departments_cbr_product-development/64; https://knowledgecommons.popcouncil.org/cgi/viewcontent.cgi?article=1063&context=departments_cbr_product-development; http://www.contraceptionjournal.org/article/S0010-7824(10)00134-4/abstract; https://secure.jbs.elsevierhealth.com/action/getSharedSiteSession?redirect=http%3A%2F%2Fwww.contraceptionjournal.org%2Farticle%2FS0010-7824%2810%2900134-4%2Fabstract&rc=0&code=contra-site; http://acw.elsevier.com/SSOCore?return=https%3A%2F%2Fsecure.jbs.elsevierhealth.com%2Faction%2FconsumeSsoCookie%3FredirectUri%3Dhttp%253A%252F%252Fwww.contraceptionjournal.org%252Faction%252FconsumeSharedSessionAction%253FJSESSIONID%253DaaaJk2yqs7JeocfEBo4xv%2526MAID%253DssRdRSHinxv%25252B%25252BtWOY76KdA%25253D%25253D%2526SERVER%253DWZ6myaEXBLEt1UgI9cIkvA%25253D%25253D%2526ORIGIN%253D165921372%2526RD%253DRD; http://acw.elsevier.com/SSOCore/?return=https%3A%2F%2Fsecure.jbs.elsevierhealth.com%2Faction%2FconsumeSsoCookie%3FredirectUri%3Dhttp%253A%252F%252Fwww.contraceptionjournal.org%252Faction%252FconsumeSharedSessionAction%253FJSESSIONID%253DaaaJk2yqs7JeocfEBo4xv%2526MAID%253DssRdRSHinxv%25252B%25252BtWOY76KdA%25253D%25253D%2526SERVER%253DWZ6myaEXBLEt1UgI9cIkvA%25253D%25253D%2526ORIGIN%253D165921372%2526RD%253DRD; https://secure.jbs.elsevierhealth.com/action/consumeSsoCookie?redirectUri=http%3A%2F%2Fwww.contraceptionjournal.org%2Faction%2FconsumeSharedSessionAction%3FJSESSIONID%3DaaaJk2yqs7JeocfEBo4xv%26MAID%3DssRdRSHinxv%252B%252BtWOY76KdA%253D%253D%26SERVER%3DWZ6myaEXBLEt1UgI9cIkvA%253D%253D%26ORIGIN%3D165921372%26RD%3DRD&acw=&utt=; http://linkinghub.elsevier.com/retrieve/pii/S0010782410001344; http://acw.elsevier.com/SSOCore?return=https%3A%2F%2Fsecure.jbs.elsevierhealth.com%2Faction%2FconsumeSsoCookie%3FredirectUri%3Dhttp%253A%252F%252Fwww.contraceptionjournal.org%252Faction%252FconsumeSharedSessionAction%253FJSESSIONID%253Daaa_7fsyCzQ04-ZPgjnxv%2526MAID%253DArEdGYcIXsdYInKv9%25252B9EHA%25253D%25253D%2526SERVER%253DWZ6myaEXBLF%25252FdY29RpN4fA%25253D%25253D%2526ORIGIN%253D699116348%2526RD%253DRD; http://acw.elsevier.com/SSOCore/?return=https%3A%2F%2Fsecure.jbs.elsevierhealth.com%2Faction%2FconsumeSsoCookie%3FredirectUri%3Dhttp%253A%252F%252Fwww.contraceptionjournal.org%252Faction%252FconsumeSharedSessionAction%253FJSESSIONID%253Daaa_7fsyCzQ04-ZPgjnxv%2526MAID%253DArEdGYcIXsdYInKv9%25252B9EHA%25253D%25253D%2526SERVER%253DWZ6myaEXBLF%25252FdY29RpN4fA%25253D%25253D%2526ORIGIN%253D699116348%2526RD%253DRD; https://secure.jbs.elsevierhealth.com/action/consumeSsoCookie?redirectUri=http%3A%2F%2Fwww.contraceptionjournal.org%2Faction%2FconsumeSharedSessionAction%3FJSESSIONID%3Daaa_7fsyCzQ04-ZPgjnxv%26MAID%3DArEdGYcIXsdYInKv9%252B9EHA%253D%253D%26SERVER%3DWZ6myaEXBLF%252FdY29RpN4fA%253D%253D%26ORIGIN%3D699116348%26RD%3DRD&acw=&utt=
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know